Clinical Trial Update: A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of SYH2053 in Chinese participants with non-familial hypercholesterolemia and mixed hyperlipidemia has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Hyperlipidemia

Drugs mentioned

• SYH2053

Snippet

Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Conditions: Hypercholesterolemia and Mixed Hyperlipidemia | Phase 2 | Status: COMPLETED